Document is current
Any future updates will be listed below
-
Authors
Antwi-Boasiako, Charles
Andemariam, Biree
Colombatti, Raffaella
Asare, Eugenia Vicky
Strunk, Crawford
Piccone, Connie M.
Manwani, Deepa
Boruchov, Donna
Farooq, Fatimah
Urbonya, Rebekah
Wilson, Samuel
Boatemaa, Gifty Dankwah
Perrotta, Silverio
Sainati, Laura
Rivers, Angela
Rao, Sudha
Zempsky, William
Ekem, Ivy
Sey, Fredericka
Segbefia, Catherine
Inusa, Baba
Tartaglione, Immacolata
Campbell, Andrew D.
-
Funding
Funding for this research was provided by:
National Institute on Minority Health and Health Disparities (5T37MD001425-19)
- License Information
-
More Information
Article History
Received: 13 January 2020
Accepted: 25 April 2020
First Online: 6 May 2020
Compliance with ethical standards
:
: <b>A Campbell</b>: Research Funding from Global Blood Therapeutics, Novartis, Cyclerion; Consultancy for Global Blood Therapeutics, Cyclerion and Bluebird Bio; <b>D Manwani:</b> Research funding from Grifols; Consultancy for Novartis, Pfizer, Blood Therapeutics; <b>B Andemariam:</b> Consultancy for Novartis, Pfizer, NovoNordisk, Emmaus, Cyclerion, Terumo, Sanofi; DSMB: Global Blood Therapeutics; Research Funding: Imara; <b>B Inusa:</b> Education Funding: Novartis Ast raZeneca, Global Blood Therapeutics, Celgene, Vertex; <b>C. Strunk</b>: Consultancy Global Blood Therapeutics and Novartis; <b>C Piccone</b>: Consultancy for Global Blood Therapeutics and Novartis; <b>R Colombatti:</b> Research Funding: Global Blood Therapeutics, Novartis.
: With the exception of Azienda Ospedaliera-Università di Padova, where there was a previously IRB-approved SCD Registry, IRB approval was obtained at all sites, and written informed consent was obtained from each patient and/or parent/guardian. Ethical approval for the study was sought from the Ethical and Protocol Review Committee of each participating site.
